Court documents filed in Alaska’s lawsuit against Eli Lilly & Co. over its marketing of the antipsychotic medication Zyprexa say that the drugmaker encouraged its sales division to downplay the risks of the drug in order to boost profits. Additionally, the documents say that Lilly instructed sales people to encourage doctors to prescribe the drug for uses not indicated on the label. At least 30 other states are currently investigating the company’s marketing practices for Zyprexa. Alaska settled its suit against the company earlier this year for $15 million.
Eli Lilly sold $4.76 Billion worth of Zyprexa alone last year, adding up to almost one-quarter of the company’s total revenues.
In my opinion, they should have to pay a lot more than $15 Million for their wrongful conduct.
You can read more in Bloomberg HERE.
